Increased bone mass with pamidronate treatment in rheumatoid arthritis: Results of a three-year randomized, double-blind trial

Arthritis and Rheumatism

Volumn 39, Issue 3, 1996, Pages 396-402

  Eggelmeijer, Frank ^a   Papapoulos, Socrates E ^a   Van Paassen, Henk C ^b   Dijkmans, Ben A C ^a   Valkema, Roelf ^a   Westedt, Marie Louise ^c   Landman, Jan Otto ^a   Pauwels, Ernest K J ^a   Breedveld, Ferdinand C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CYTOSTATIC AGENT; GOLD SALT; PAMIDRONIC ACID; PENICILLAMINE; PLACEBO; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOREARM; GASTROINTESTINAL SYMPTOM; HIP; HUMAN; JOINT RADIOGRAPHY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE DENSITY; DIPHOSPHONATES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLACEBOS; WALKING;

EID: 0030007961     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390307     Document Type: Article

References (35)

1. Joffe I, Epstein S: Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 20:256-272, 1991
2. Laan RFJM, van Riel PLCM, van de Putte LBA: Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 51:826-832, 1992
3. Eggelmeijer F, Camps JAJ, Valkema R, Papapoulos SE, Pauwels EKJ, Dijkmans BAC, Breedveld FC: Bone mineral density in ambulant non-steroid treated female patients with rheumatoid arthritis. Clin Exp Rheumatol 11:381-385, 1993
4. Hooyman JR, Melton LJ III, Nelson AM, O'Fallon WM, Riggs BL: Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 27:1353-1361, 1984
5. Beat AM, Bloch DA, Fries JF: Predictors of fractures in early rheumatoid arthritis. J Rheumatol 18:804-808, 1991
6. Spector TD, Hall GM, McCloskey EV, Kanis JA: Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 306:558-561, 1993
7. Gough AKS, Liley J, Eyre S, Holder RL, Emery P: Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23-27, 1994
8. Sambrook PN: Osteoporosis in rheumatoid arthritis: what is the role of antirheumatic therapy? Lancet 344:3-4, 1994
9. Fleisch H: Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs 42:919-944, 1991
10. Bijvoet OLM, Vellenga CJLR, Harinck HIJ: Paget's disease of bone: assessment, therapy and secondary prevention. In, Clinical Disorders of Bone Mineral Metabolism. Edited by M Kleerkoper, SM Krane. New York, Mary Ann Liebert Inc. 1989
11. Valkema R, Vismans FJFE, Papapoulos SE, Pauwels EKJ, Bijvoet OLM: Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 5:183-192, 1989
12. Adami S, Baroni MC, Broggini M, Carratelli L, Caruso I, Gnessi L, Laurenzi M, Lombardi A, Norbiato G, Ortolani S: Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin. Osteoporosis Int 3 (suppl 3):21-27, 1993
13. Reid IR, Wattie DJ, Evans MC, Gamble JD, Stapleton JF, Cornisk J: Continuous therapy with panidronate, a potent bisphosphatae, in postmenopausal osteoporosis. J Clin Endocrinol Metab 79:1595-1599, 1994
14. Papapoulos SE, Landman JD, Bijvoet OLM, Löwik CWGM, Valkema R, Pauwels EKJ, Vermeij P: The use of bisphosphonate in the treatment of osteoporosis. Bone 13:541-549, 1992
15. Papapoulos SE: The role of bisphosphonates in the prevention and treatment of osteoporosis. Am J Med 95(suppl 5A):48-51, 1993
16. Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BAC, Breedveld FC: Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double-blind placebo controlled study. J Rheumatol 21:2016-2020, 1994
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
18. Steinbrocker O, Traeger CH, Batterman EC: Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662, 1949
19. Kellgren JH, Jeffrey MR, Ball J: Atlas of standard radiographs of arthritis. Oxford, Blackwell Scientific Publications, 1963
20. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37:393-406, 1968
21. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145, 1980
22. Prockop DJ, Undenfriend S: A specific method of the analysis of hydroxyproline in tissues and urine. Anal Biochem 1:228-233, 1960
23. Shenstone BD, Mahmoud A, Wood wars R, Elvins D, Palmer R, Ring EF, Bhalla AK: Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33:541-545, 1994
24. Van den Brink HR, Lems WF, Van Everdingen AA, Bijlsma JWJ: Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis 52:302-305, 1993
25. Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG: Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48:535-538, 1989
26. Laan RFJM, van Riel PLCM, van de Putte LBA, van Erning LJTO, van 't Hof MA, Lemmens JAM: Low-dose prednisone induced rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 119:963-968, 1993
27. Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P: Excretion of pyridinoline crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 53:14-17, 1994
28. Eggelmeijer F, Papapoulos SE, Westedt ML, van Paassen HC, Dijkmans BAC, Breedveld FC: Bone metabolism in rheumatoid arthritis: relation to disease activity. Br J Rheumatol 32:387-391, 1993
29. Harinck HIJ, Bijvoet OLM, Blanksma HJ, Dahlinghaus-Nienhuys PJ: Efficacious management with amino bisphosphonates (APD) in Paget's disease of bone. Clin Orthop 217:79-98, 1987
30. Van Holten-Verzantvoort AT, Kroon HM, Bijvoet OLM, Cleton FJ, Beex LVAM, Blijham G, Hermans J, Neijt JP, Papapoulos SE, Sleeboom HP, Vermey P, Zwinderman AH: Palliative pamidronate treatment in patients with bone metastasis for breast cancer. J Clin Oncol 11:491-498, 1993
31. Flora L: Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthritis Rheum 22:340-346, 1979
32. Barbier A, Brelière JC, Remandet B, Roncucci R: Studies on the chronic phase of adjuvant arthritis: effect of SR 41319 a new diphosphonate. Ann Rheum Dis 45:67-74, 1986
33. Bijvoet OLM, Frijlink WB, Jie K, van der Linden H, Meijer CJLM, Mulder H, van Paassen HC, Reitsma PH, te Velde J, de Vries E, van der Wey JP: APD in Paget's disease of bone: role of the mononuclear phagocyte system? Arthritis Rheum 23: 1193-1204, 1980
34. Tan PLJ, Ames R, Yeoman S, Ibbertson HK, Caughey DE: Effects of aminobisphosphonate infusion on biochemical indices of bone metabolism in rheumatoid arthritis. Preliminary report. Br J Rheumatol 28:325-328, 1989
35. Maccagno A, Di Giorgio E, Roldan EJA, Caballero LE, Perez Lloret A: Double blind radiological assessment of continuous oral pamidronate in patients with rheumatoid arthritis. Scand J Rheumatol 23:211-214, 1994